Cargando…

Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials

BACKGROUND AND HYPOTHESIS: Antipsychotic-induced weight gain is associated with alterations to the composition of the gut microbiota. The purpose of this study was to determine the effect of probiotics plus dietary fiber on antipsychotic-induced weight gain. STUDY DESIGN: Two sequential, randomized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jing, Kang, Dongyu, Zhang, Fengyu, Yang, Ye, Liu, Chenchen, Xiao, Jingmei, Long, Yujun, Lang, Bing, Peng, Xingjie, Wang, Weiyan, Wang, Xiaoyi, Liu, Fangkun, Davis, John M, Zhao, Jingping, Wu, Renrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212091/ https://www.ncbi.nlm.nih.gov/pubmed/35569003 http://dx.doi.org/10.1093/schbul/sbac044

Ejemplares similares

The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial
por: Huang, Jing, et al.
Publicado: (2022)

Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial
por: Liu, Chenchen, et al.
Publicado: (2021)

Association between olanzapine concentration and metabolic dysfunction in drug-naive and chronic patients: similarities and differences
por: Kang, Dongyu, et al.
Publicado: (2022)

Optimizing and Individualizing the Pharmacological Treatment of First-Episode Schizophrenic Patients: Study Protocol for a Multicenter Clinical Trial
por: Xiao, Jingmei, et al.
Publicado: (2021)

The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance
por: Li, Ranran, et al.
Publicado: (2018)

Cognitive effects of atypical antipsychotic drugs in first-episode drug-naïve schizophrenic patients
por: Wang, Juan, et al.
Publicado: (2013)

Family-based case-control study of homotopic connectivity in first-episode, drug-naive schizophrenia at rest
por: Guo, Wenbin, et al.
Publicado: (2017)

Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia
por: Zhu, Furong, et al.
Publicado: (2018)

Reduced Brain Activity in the Right Putamen as an Early Predictor for Treatment Response in Drug-Naive, First-Episode Schizophrenia
por: Wu, Renrong, et al.
Publicado: (2019)

Decreased Resting-State Interhemispheric Functional Connectivity Correlated with Neurocognitive Deficits in Drug-Naive First-Episode Adolescent-Onset Schizophrenia
por: Liu, Yi, et al.
Publicado: (2017)

Resting-state cerebellar-cerebral networks are differently affected in first-episode, drug-naive schizophrenia patients and unaffected siblings
por: Guo, Wenbin, et al.
Publicado: (2015)

Olanzapine Promotes the Occurrence of Metabolic Disorders in Conditional TCF7L2-Knockout Mice
por: Yang, Ye, et al.
Publicado: (2022)

Bidirectional Causal Connectivity in the Cortico-Limbic-Cerebellar Circuit Related to Structural Alterations in First-Episode, Drug-Naive Somatization Disorder
por: Li, Ranran, et al.
Publicado: (2018)

Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex
por: Shao, Tiannan, et al.
Publicado: (2023)

Hyperactivity of the default-mode network in first-episode, drug-naive schizophrenia at rest revealed by family-based case–control and traditional case–control designs
por: Guo, Wenbin, et al.
Publicado: (2017)

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
por: Liu, Jiahong, et al.
Publicado: (2021)

Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
por: Huang, Jing, et al.
Publicado: (2020)

Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials
por: Kang, Dongyu, et al.
Publicado: (2018)

Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis
por: Hatziagelaki, Erifili, et al.
Publicado: (2019)

Public Behavior Change, Perceptions, Depression, and Anxiety in Relation to the COVID-19 Outbreak
por: Huang, Jing, et al.
Publicado: (2020)

Patients with first-episode, drug-naive schizophrenia and subjects at ultra-high risk of psychosis shared increased cerebellar-default mode network connectivity at rest
por: Wang, Houliang, et al.
Publicado: (2016)

Identifying and revealing different brain neural activities of cognitive subtypes in early course schizophrenia
por: Shao, Tiannan, et al.
Publicado: (2022)

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
por: Huang, Jing, et al.
Publicado: (2020)

Weight gain with olanzapine: Drug, gender or age?
por: Jain, Sanjay, et al.
Publicado: (2006)

The Effect of Ranitidine on Olanzapine-Induced Weight Gain
por: Ranjbar, Fatemeh, et al.
Publicado: (2013)

Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
por: Yang, Ye, et al.
Publicado: (2022)

Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis
por: Correll, Christoph U, et al.
Publicado: (2023)

Enhanced Connectivity of Thalamo-Cortical Networks in First-Episode, Treatment-Naive Somatization Disorder
por: Zhao, Jin, et al.
Publicado: (2020)

Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
por: Qian, Li, et al.
Publicado: (2023)

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
por: Fitzgerald, Ita, et al.
Publicado: (2021)

Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats
por: Hu, Yueshan, et al.
Publicado: (2014)

Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment
por: Lian, Jiamei, et al.
Publicado: (2014)

Effect Of Risperidone And Olanzapine On The Metabolic Profile Of Drug Naïve Bipolar Disorder Patients.
por: Gupta, Gajal, et al.
Publicado: (2022)

Increased Nucleus Accumbens Connectivity in Resting-State Patients With Drug-Naive, First-Episode Somatization Disorder
por: Ou, Yangpan, et al.
Publicado: (2019)

The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse
por: Morgan, Andrew P., et al.
Publicado: (2014)

Olanzapine: Worsening of obsessive compulsive disorder and weight gain: case report
Publicado: (2022)

Clinical significance of increased cerebellar default-mode network connectivity in resting-state patients with drug-naive somatization disorder
por: Wang, Houliang, et al.
Publicado: (2016)

Tranylcypromine Causes Neurotoxicity and Represses BHC110/LSD1 in Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoids Model
por: Huang, Jing, et al.
Publicado: (2017)

Abnormal Default Mode Network Homogeneity in Treatment-Naive Patients With First-Episode Depression
por: Gao, Yujun, et al.
Publicado: (2018)

Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain
por: Weston-Green, Katrina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2rqmq1afhs9sdsd24f8camttok